Treating Metastatic Spinal Tumors with the targeted Radiofrequency Ablation (t-RFA) Procedure
Providing fast and lasting relief from painful metastatic spinal lesions is now possible with minimally invasive targeted radiofrequency ablation (t-RFA) procedure.
The t-RFA procedure offers dramatic improvements in the palliative treatment of metastatic spinal tumors. Conventional methods can take weeks and require multiple treatments to achieve meaningful pain reduction. By comparison, t-RFA has been clinically shown to provide patients with meaningful pain relief that is both rapid and durable.
A recent multicenter retrospective study included 128 treated lesions in 92 patients, many of whom had failed radiation therapy.
t-RFA was safe and effective, with no major complications or thermal injuries and 54% of patients reducing pain medication usage after t-RFA.
As t-RFA does not disrupt the patients’ other therapies and protocols, it expands the range of treatment options for many patients with painful spinal tumors.
Source: Anchala, et al., Pain Physician 2014; 17:317-327 • ISSN 1533-3159
Combining controlled access to the vertebral body with controlled RF energy delivery, the STAR Tumor Ablation System creates a controlled RF ablation zone. This offers physicians the ability to reduce the size and symptoms of metastatic spinal tumors in a single, minimally invasive t-RFA procedure.
Unlike patients treated with conventional radiation therapy, those patients who undergo a t-RFA procedure to treat metastatic spinal tumors may not need to delay systemic and primary cancer treatment regimens.